The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Individual brings two decades of industry experience to his new role, and has also previously worked at Refinitiv, Bloomberg ...

Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Akero Therapeutics is conducting a Phase 3 study titled A Phase ...

With a forward-price-to-earnings multiple under 15x and significant hedge fund interest, Enerflex Ltd. (NYSE:EFXT) secures a ...

An Equifax Canada report out this week found that close to 1.4 million Canadians missed a credit payment in the second ...